Discordant findings consisted mainly of rare AML fusions discovered in recent years by advanced sequencing technologies and known to be cytogenetically cryptic, for instance, CBFA2T3::GLIS2 and NUP98-fusions (Supplementary Table S5). Here, GLIS2 is linked to acute myeloid leukemia.